- Report
- January 2026
- 282 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 171 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 490 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 577 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 377 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 371 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 286 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 183 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 380 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 372 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 367 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 475 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 108 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 285 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 360 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 172 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 142 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 554 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 372 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 488 Pages
Global
From €5204EUR$5,850USD£4,515GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more